Status: Recruiting
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Evaluate the efficacy, as well as safety and pharmacokinetics, of Roluperidone in improving the negative symptoms of schizophrenia in adult subjects in Phase A of study, followed by Phase B of study to evaluate the relapse rate of Roluperidone and antipsychotic medications.
Participants needed: 380
Trial details
Phase: Phase 3Age: 18-55Biological sex: AllType: InterventionalSponsor: Minerva NeurosciencesUpdated: Jun 15, 2026Locations: 5
Eligibility criteria
Subject and subject's legal representative, if applicable, provided informed con... [+15]
Current major depressive disorder, bipolar disorder, panic disorder, obsessive c... [+26]